P

Inventor

BHATT RAMESH

US11 patents
⚠️ This page may combine multiple inventors who share the name “BHATT RAMESH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOROWITZ LAWRENCE

3 patents
US9169318B2Oct 27, 2015

Neutralizing molecules to viral antigens

HOROWITZ LAWRENCE8 citations79
US8131480B2Mar 6, 2012

Construction of diverse synthetic peptide and polypeptide libraries

HOROWITZ LAWRENCE5 citations57
US8148085B2Apr 3, 2012

Donor specific antibody libraries

HOROWITZ LAWRENCE1 citations48

JANUX THERAPEUTICS INC

2 patents
US12433953B2Oct 7, 2025

Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens

JANUX THERAPEUTICS INC0 citations59
US12161724B2Dec 10, 2024

Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens

JANUX THERAPEUTICS INC1 citations59

I2 PHARMACEUTICALS INC

2 patents
US10214580B2Feb 26, 2019

Constructs and libraries comprising antibody surrogate light chain sequences

I2 PHARMACEUTICALS INC0 citations49
US10216897B2Feb 26, 2019

Construction of diverse synthetic peptide and polypeptide libraries

I2 PHARMACEUTICALS INC0 citations45

BHATT RAMESH

1 patent
US8114967B2Feb 14, 2012

Constructs and libraries comprising antibody surrogate light chain sequences

BHATT RAMESH76 citations94

RIGEL PHARMACEUTICALS INC

1 patent
US11104737B2Aug 31, 2021

ACVR2A-specific antibody and method of treatment of muscle atrophy

RIGEL PHARMACEUTICALS INC0 citations47

TORCH THERAPEUTICS

1 patent
US11111305B2Sep 7, 2021

Method of using a bispecific antibody to conditionally inhibit a receptor signaling complex

TORCH THERAPEUTICS0 citations41

12 PHARMACEUTICALS INC

1 patent
US10017561B2Jul 10, 2018

Neutralizing molecules to influenza viruses

12 PHARMACEUTICALS INC0 citations41